VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
NASDAQ:VMD • CA92663R1055
8.85 USD
+0.15 (+1.72%)
At close: Mar 2, 2026
8.85 USD
0 (0%)
After Hours: 3/2/2026, 8:00:02 PM
Taking everything into account, VMD scores 6 out of 10 in our fundamental rating. VMD was compared to 101 industry peers in the Health Care Providers & Services industry. VMD has an excellent profitability rating, but there are some minor concerns on its financial health. VMD is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make VMD suitable for growth investing!
1. Profitability
1.1 Basic Checks
- VMD had positive earnings in the past year.
- VMD had a positive operating cash flow in the past year.
- VMD had positive earnings in each of the past 5 years.
- In the past 5 years VMD always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of VMD (6.73%) is better than 88.12% of its industry peers.
- The Return On Equity of VMD (10.19%) is better than 72.28% of its industry peers.
- VMD has a Return On Invested Capital of 7.79%. This is in the better half of the industry: VMD outperforms 73.27% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for VMD is in line with the industry average of 9.12%.
- The 3 year average ROIC (7.66%) for VMD is below the current ROIC(7.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROIC | 7.8% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
- VMD has a Profit Margin of 5.34%. This is amongst the best in the industry. VMD outperforms 80.20% of its industry peers.
- VMD's Profit Margin has declined in the last couple of years.
- With a decent Operating Margin value of 6.83%, VMD is doing good in the industry, outperforming 72.28% of the companies in the same industry.
- VMD's Operating Margin has declined in the last couple of years.
- VMD has a better Gross Margin (57.89%) than 80.20% of its industry peers.
- VMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VMD is destroying value.
- VMD has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, VMD has more shares outstanding
- VMD has a better debt/assets ratio than last year.
2.2 Solvency
- VMD has an Altman-Z score of 5.14. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
- VMD's Altman-Z score of 5.14 is amongst the best of the industry. VMD outperforms 86.14% of its industry peers.
- VMD has a debt to FCF ratio of 3.93. This is a good value and a sign of high solvency as VMD would need 3.93 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.93, VMD is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
- VMD has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
- VMD has a Debt to Equity ratio of 0.15. This is in the better half of the industry: VMD outperforms 73.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Altman-Z | 5.14 |
ROIC/WACC0.9
WACC8.66%
2.3 Liquidity
- VMD has a Current Ratio of 1.13. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.13, VMD is in line with its industry, outperforming 40.59% of the companies in the same industry.
- VMD has a Quick Ratio of 1.01. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.01, VMD is not doing good in the industry: 60.40% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
- VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.22%, which is quite impressive.
- The Earnings Per Share has been growing slightly by 4.01% on average over the past years.
- The Revenue has grown by 18.90% in the past year. This is quite good.
- The Revenue has been growing by 22.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
3.2 Future
- Based on estimates for the next years, VMD will show a very strong growth in Earnings Per Share. The EPS will grow by 30.77% on average per year.
- VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.73% yearly.
EPS Next Y24.45%
EPS Next 2Y30.21%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue Next Year21.57%
Revenue Next 2Y21.93%
Revenue Next 3Y19.73%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 26.82, which means the current valuation is very expensive for VMD.
- VMD's Price/Earnings ratio is in line with the industry average.
- VMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.13, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 18.64, which indicates a rather expensive current valuation of VMD.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of VMD indicates a somewhat cheap valuation: VMD is cheaper than 66.34% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 28.11. VMD is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 18.64 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, VMD is valued cheaper than 83.17% of the companies in the same industry.
- The rest of the industry has a similar Price/Free Cash Flow ratio as VMD.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 62.48 | ||
| EV/EBITDA | 7.61 |
4.3 Compensation for Growth
- VMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- VMD has a very decent profitability rating, which may justify a higher PE ratio.
- VMD's earnings are expected to grow with 30.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.1
PEG (5Y)6.68
EPS Next 2Y30.21%
EPS Next 3Y30.77%
5. Dividend
5.1 Amount
- No dividends for VMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
8.85
+0.15 (+1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-04 2026-03-04/amc
Inst Owners66.99%
Inst Owner ChangeN/A
Ins Owners13.52%
Ins Owner Change19%
Market Cap336.48M
Revenue(TTM)254.79M
Net Income(TTM)13.61M
Analysts80
Price Target13.26 (49.83%)
Short Float %1.14%
Short Ratio2.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-2.17%
Min EPS beat(4)-5.7%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-9.3%
EPS beat(12)3
Avg EPS beat(12)-5.6%
EPS beat(16)4
Avg EPS beat(16)-8.04%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-1.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)-0.38%
Revenue beat(12)7
Avg Revenue beat(12)-0.14%
Revenue beat(16)11
Avg Revenue beat(16)0.8%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.82 | ||
| Fwd PE | 18.64 | ||
| P/S | 1.32 | ||
| P/FCF | 62.48 | ||
| P/OCF | 6.94 | ||
| P/B | 2.52 | ||
| P/tB | 4.56 | ||
| EV/EBITDA | 7.61 |
EPS(TTM)0.33
EY3.73%
EPS(NY)0.47
Fwd EY5.36%
FCF(TTM)0.14
FCFY1.6%
OCF(TTM)1.27
OCFY14.4%
SpS6.7
BVpS3.51
TBVpS1.94
PEG (NY)1.1
PEG (5Y)6.68
Graham Number5.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROCE | 11% | ||
| ROIC | 7.8% | ||
| ROICexc | 8.38% | ||
| ROICexgc | 14.13% | ||
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% | ||
| FCFM | 2.11% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexgc growth 3Y2.65%
ROICexgc growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 157.16% | ||
| Cap/Sales | 16.91% | ||
| Interest Coverage | 21.97 | ||
| Cash Conversion | 108.16% | ||
| Profit Quality | 39.56% | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 5.14 |
F-Score5
WACC8.66%
ROIC/WACC0.9
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
EPS Next Y24.45%
EPS Next 2Y30.21%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
Revenue Next Year21.57%
Revenue Next 2Y21.93%
Revenue Next 3Y19.73%
Revenue Next 5YN/A
EBIT growth 1Y7.34%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year245.03%
EBIT Next 3Y64.45%
EBIT Next 5YN/A
FCF growth 1Y-66.11%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y22.32%
OCF growth 3Y20.23%
OCF growth 5Y15.41%
VIEMED HEALTHCARE INC / VMD FAQ
What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to VMD.
Can you provide the valuation status for VIEMED HEALTHCARE INC?
ChartMill assigns a valuation rating of 5 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.
Can you provide the profitability details for VIEMED HEALTHCARE INC?
VIEMED HEALTHCARE INC (VMD) has a profitability rating of 7 / 10.
What are the PE and PB ratios of VIEMED HEALTHCARE INC (VMD) stock?
The Price/Earnings (PE) ratio for VIEMED HEALTHCARE INC (VMD) is 26.82 and the Price/Book (PB) ratio is 2.52.
What is the earnings growth outlook for VIEMED HEALTHCARE INC?
The Earnings per Share (EPS) of VIEMED HEALTHCARE INC (VMD) is expected to grow by 24.45% in the next year.